Evaluation of Trilysine-Cross-Linked Gellan Gum for Intratumoral Delivery of Anti-PD-1 in a Colorectal Cancer Mouse Tumor Model
ACS Biomaterials Science & Engineering · 2026
DOI: 10.1021/acsbiomaterials.5c01503 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2026. Verfasst von Carolina Villarreal-Otalvaro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, Massachusetts 01609, United States. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Polysaccharides, Bacterial, Lysine, Programmed Cell Death 1 Receptor. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Worcester Polytechnic Institute, Boston Scientific Corporation.
Abstract (Originalsprache)
Colorectal cancer (CRC) is the second leading cause of death in the United States in the adult population. When detected at early stages, the survival rate is higher than 70% but when diagnosed at a metastatic stage, the 5-year survival rate significantly declines to 15%. In recent years, immunotherapy has shown promising results in a selective patient population with advanced or metastatic CRC with microsatellite instability (MSI) and mismatch repair (MMR). Hydrogels are a growing field of research to improve the delivery of monoclonal antibodies. In this work, a gellan gum-based (GG) hydrogel noncovalently cross-linked using trilysine (TLA) was characterized for its drug release and diffusion properties. A partial release of the checkpoint inhibitor anti-programmed death-1 (aPD-1) was observed with an almost 40% cumulative release within the first 24 h. FRAP analysis showed varying diffusion rates (μm2/s) for Atto 488-IgG (2.63 ± 0.32), 60-76 kDa FITC-Dextran (2.65 ± 0.31), and 150 kDa FITC-Dextran (2.80 ± 0.83), with a 70-90% recovery postbleaching. Additionally, intratumoral delivery of aPD-1 was evaluated in a CRC mouse (C57BL/6) tumor model inoculated with MC38 cells. Quantification of aPD-1 in the plasma and tumor showed an increase in concentration by 1.5- and 3-fold, respectively, when delivered using the intratumoral hydrogel route in comparison with either intraperitoneal (i.p.) or drug-free intratumoral administration. Overall, this noncytotoxic hydrogel provided an alternative delivery route for aPD-1, maximizing its presence both in circulating blood and in the treatment site, serving as a simple localized delivery system in CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, Massachusetts 01609, United States.
- Boston Scientific Corporation, Marlborough, Massachusetts 01752, United States.
- Department of Biology and Biotechnology, Worcester Polytechnic Institute, Worcester, Massachusetts 01609, United States.
- Bioinformatics and Computational Biology Program, Worcester Polytechnic Institute, Worcester, Massachusetts 01609, United States.
ORCID-Profile: Jeannine M Coburn
Förderung
- Worcester Polytechnic Institute
- Boston Scientific Corporation
Zitieren
APA
Villarreal-Otalvaro, C., Luna, F., Ramos Espinoza, R. A., Lombardini, E. D., Paxton, Z., Vidali, L., & Coburn, J. M. (2026). Evaluation of Trilysine-Cross-Linked Gellan Gum for Intratumoral Delivery of Anti-PD-1 in a Colorectal Cancer Mouse Tumor Model. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.5c01503
Vancouver
Villarreal-Otalvaro C, Luna F, Ramos Espinoza RA, Lombardini ED, Paxton Z, Vidali L, et al. Evaluation of Trilysine-Cross-Linked Gellan Gum for Intratumoral Delivery of Anti-PD-1 in a Colorectal Cancer Mouse Tumor Model. ACS Biomaterials Science & Engineering. 2026. doi:10.1021/acsbiomaterials.5c01503
BibTeX
@article{VillarrealOtalvaro2026,
author = {Villarreal-Otalvaro, Carolina and Luna, Francini and Ramos Espinoza, Rosangel A and Lombardini, Eric D and Paxton, Zephyr and Vidali, Luis and Coburn, Jeannine M},
title = {Evaluation of Trilysine-Cross-Linked Gellan Gum for Intratumoral Delivery of Anti-PD-1 in a Colorectal Cancer Mouse Tumor Model},
journal = {ACS Biomaterials Science & Engineering},
year = {2026},
doi = {10.1021/acsbiomaterials.5c01503}
}
EUVIMED